CNBC February 25, 2025
Key Points
– Eli Lilly released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage for the blockbuster injection, such as those with Medicare.
– The company is offering those vials through its direct-to-consumer website, LillyDirect, which started offering lower doses of the drug in vials in August.
– The company is selling 7.5 milligram and 10 milligram vials of Zepbound for $499 per month when patients fill their first prescription, and any time they refill within 45 days of their previous delivery. Otherwise, those two doses will be priced at $599 and $699, respectively.
Eli Lilly on Tuesday released higher...
Today's Sponsors
Today's Sponsor